5 April 2017
23 January 2017
Amendment of the TRIPS Agreement
WTO members on 6 December 2005 approved changes to the WTO’s intellectual property (TRIPS) agreement in order to make permanent a decision on patents and public health originally adopted in 2003. This was formally
28 February 2016
Civil Society Calls on WHO to Include Report from UN’s High Level Panel on Medicines …
Dear Director General Dr. Margaret Chan Request to include discussion of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines at the next WHO Board meeting As members of the Make
12 January 2016
Morocco: Creation of a collective for t the right to health in the framework of the n…
At a time when the Kingdom of Morocco and the European Union are preparing to resume negotiations on the “comprehensive and thorough free trade agreement” (FTAA), Moroccan civil society unites to bell Alarm about
1 October 2015
HCV
Hepatitis C: Hepatitis C virus (HCV), is a major health concern in MENA. A country like Egypt for example has the highest prevalence of HCV in the world. Pakistan has also a significant number
26 June 2015
Launch of Moroccan Generic Sofosbuvir: A Victory for the Wide-spread Use HCV Treatmen…
According to the Ministry of Health, 625,000 people are infected by HCV, 1.6% of the general population of Morocco. Of those infected, 267,000 people have active chronic infection requiring treatment. Until recently, the management
20 May 2015
Treatment Advocates Denounce Gilead’s Embargo against Thousands of Tunisians Sufferin…
The Tunisian Association of Fight against STDs and AIDS (ATL Tunis) and the International Treatment Preparedness Coalition in MENA Region (ITPC-MENA) denounce the refusal of Gilead Sciences to make their drug against the Hepatitis
28 February 2014
Pharma Refuses to Ensure Access to Lifesaving Hepatitis C Treatment at Global Meeting
Bangkok, Thailand, February 28, 2014 —Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis C virus
28 July 2013